Skip to main content
. 2014 Feb 18;9(2):e88706. doi: 10.1371/journal.pone.0088706

Figure 4. The relationship of FCM score with transfusion dependency and disease progression in MDS.

Figure 4

55 of 180 patients with low-grade MDS were transfusion dependent. There is no obvious difference in FCM total score (A), early scoring (B) and advanced scoring (C) between the patients with and without transfusion dependency. 18 of 126 patients with low-grade MDS progressed towards RAEB-1 or RAEB-2 or AML. There is no obvious difference in FCM total score (D) between the patients with and without disease progression (P = 0.153). However, the patients with progression toward high-grade MDS or AML showed significantly higher advanced scoring (F) but lower early scoring (E) than the patients with disease stabilization (P<0.001; P = 0.002).